Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Protecting mechanism of Swietenia macrophylla ethanol extract nanoparticle on streptozotocin induced renal damage in rat.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: Faculty of Veterinary Medicine, University of Tripoli Country of Publication: Libya NLM ID: 101653182 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2218-6050 (Electronic) Linking ISSN: 22186050 NLM ISO Abbreviation: Open Vet J Subsets: MEDLINE
    • بيانات النشر:
      Publication: Nov. 2016 -: Tripoli, Libya : Faculty of Veterinary Medicine, University of Tripoli
      Original Publication: Tripoli, Libya : Faculty of Veterinary Medicine, University of Tripoli : National Authority for Scientific Research
    • الموضوع:
      Diabetes Mellitus, Experimental*/chemically induced ; Diabetes Mellitus, Experimental*/pathology ; Hyperglycemia*/pathology ; Hyperglycemia*/veterinary ; Meliaceae*; Animals ; Rats ; Antioxidants/pharmacology ; Creatinine/pharmacology ; Ethanol/pharmacology ; Kidney/pathology ; Reactive Oxygen Species/pharmacology ; Streptozocin/pharmacology ; Superoxide Dismutase/pharmacology
    • نبذة مختصرة :
      Background: Hyperglycemia increases reactive oxygen species (ROS), which contributes to diabetic complications such as kidney cell damage. Antioxidant administration could inhibit ROS and kidney cell damage commonly seen in hyperglycemia.
      Aim: We want to demonstrate that the antioxidant properties of Swietenia macrophylla ethanol extract nanoparticles can prevent kidney cell damage brought on by streptozotocin (STZ) in the current investigation.
      Methods: This study employs high-energy ball milling to produce nanoparticles from S. macrophylla extract. Additionally, dynamic light scattering (DLS) is utilized to characterize the nanoparticle sizes of the S. macrophylla ethanol extract. Five groups, each consisting of 8 rats, were formed from 40 rats. Control rats received distilled water, the diabetic rats were administered STZ injections, while S. macrophylla rats were given S. macrophylla extract nanoparticles orally and STZ injection. After the trial, blood from a rat was drawn intracardially to check the levels of blood urea nitrogen (BUN) and creatinine. The levels of superoxide dismutase (SOD), glutathione peroxidase (GPx), and malondialdehyde (MDA) were then assessed in kidney tissue samples. Histological alterations were evaluated in kidney section samples.
      Results: A DLS analysis estimated the size of the S. macrophylla ethanol extract nanoparticles to be about 91.50 ± 23.06 nm. BUN and creatinine levels were significantly raised after STZ treatment. STZ significantly decreased SOD and GPx levels in kidney tissue while raising MDA levels ( p < 0.05). Swietenia macrophylla ethanol extract nanoparticle caused the decreased levels of BUN and creatinine in blood to normal levels ( p < 0.05), indicating that S. macrophylla ethanol extract prevented the STZ-induced kidney cell damage. Additionally, S. macrophylla nanoparticles significantly raise GPx and SOD levels in kidney tissue while lowering MDA levels ( p < 0.05). These actions are thought to have prevented kidney histological alterations (degeneration and necrosis) in diabetic rats.
      Conclusion: According to these results, the anti-oxidative stress properties of S. macrophylla nanoparticles make them potentially effective nephroprotective therapies for STZ-induced kidney cell damage.
      Competing Interests: All authors declare that there is no conflict of interest.
    • References:
      Biomedicines. 2022 Apr 03;10(4):. (PMID: 35453592)
      Nutrients. 2023 Jan 21;15(3):. (PMID: 36771275)
      Pharmaceuticals (Basel). 2023 Jul 07;16(7):. (PMID: 37513885)
      Drug Des Devel Ther. 2021 Feb 16;15:589-600. (PMID: 33623368)
      Saudi Pharm J. 2016 Sep;24(5):547-553. (PMID: 27752226)
      Evid Based Complement Alternat Med. 2022 May 31;2022:3405871. (PMID: 35685736)
      Biomed Rep. 2021 May;14(5):42. (PMID: 33728048)
      Front Med. 2020 Oct;14(5):583-600. (PMID: 32248333)
      Oxid Med Cell Longev. 2019 May 12;2019:5953685. (PMID: 31214280)
      J Pharm Pharmacol. 2020 Nov;72(11):1615-1628. (PMID: 32754951)
      Biomed Pharmacother. 2018 Dec;108:656-662. (PMID: 30245465)
      Cell Death Dis. 2018 Jan 25;9(2):119. (PMID: 29371661)
      Int J Physiol Pathophysiol Pharmacol. 2019 Jun 15;11(3):45-63. (PMID: 31333808)
    • Contributed Indexing:
      Keywords: Antioxidant; Diabetes; Nanoparticles; Nephroprotector; Swietenia macrophylla
    • الرقم المعرف:
      0 (Antioxidants)
      AYI8EX34EU (Creatinine)
      3K9958V90M (Ethanol)
      0 (Reactive Oxygen Species)
      5W494URQ81 (Streptozocin)
      EC 1.15.1.1 (Superoxide Dismutase)
    • الموضوع:
      Date Created: 20240131 Date Completed: 20240221 Latest Revision: 20241023
    • الموضوع:
      20241023
    • الرقم المعرف:
      PMC10824090
    • الرقم المعرف:
      10.5455/OVJ.2023.v13.i12.12
    • الرقم المعرف:
      38292712